The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merrimack
A phase 2 study of seribantumab (MM-121) in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive (HRG+), locally advanced or metastatic non-small cell lung cancer (NSCLC).
 
Lecia V. Sequist
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Ian Churchill Anderson
Consulting or Advisory Role - Genentech
 
Nathan Demars
No Relationships to Disclose
 
Enriqueta Felip
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche/Genentech
 
Wael A. Harb
Employment - Unity Health Care
 
Rudolf M. Huber
Honoraria - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Novartis; Roche/Genentech
Research Funding - Pierre Fabre
 
Art J. Kudla
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Jean Kyung Lee
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - Genentech
Travel, Accommodations, Expenses - Genentech
 
Sara Mathews
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Ty McClure
Employment - Merrimack
 
Jorge J. Nieva
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - Genentech
Research Funding - AstraZeneca; Clovis Oncology; Merrimack
 
Maurice Perol
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Recombio; Synta
Research Funding - Boehringer Ingelheim (Inst)
 
Alexander I. Spira
Honoraria - Novartis; Roche
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; MedImmune; Roche
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Roche
 
Akos Gabor Czibere
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack